Pfizer and BioNTech Receive First U.S. Fda Emergency Use Authorization of a COVID-19 Vaccine Booster
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) has [...]
Digital Therapeutics Alliance announces new Resource Partner Program to Accelerate Access and Impact of Digital Therapeutics for Patients Worldwide
ARLINGTON, Va. , Sept. 23, Today, the Digital Therapeutics Alliance (DTA), a global non-profit trade association of industry leaders and [...]
The road to Aduhelm: What one ex-FDA adviser called ‘probably the worst drug approval decision in recent US history’ for an Alzheimer’s treatment
The road to Aduhelm: What one ex-FDA adviser called ‘probably the worst drug approval decision in recent US history’ for [...]
AVBCC to Host Preconference Workshop on Value-Based Contracting at 2021 AVBCC Summit
CRANBURY, N.J. Association for Value-Based Cancer Care ( AVBCC ) is proud to announce a preconference workshop on “Value-Based Contracting [...]
Zitter Pulse Check: Multiple Sclerosis
Zitter Pulse Check: Multiple Sclerosis Coverage Multiple sclerosis (MS) is a high-cost category with an increasing number of therapies that [...]
Government Pledges To Reduce Overprescribing Of Medicines
Government Pledges To Reduce Overprescribing Of Medicines The Government will take action to prevent medicines being prescribed unnecessarily, as a [...]
Axinn’s Landmon Provides an Expert Legal Opinion on HHS’ Drug Price Strategy
\n\nCan President Biden succeed in his plan to rein in the soaring cost of prescription drug medicine? A blueprint for [...]
Rare Disease Meeting Highlights FDA’s RDCA-DAP Research Resource
A recent rare disease meeting brought together more than 400 attendees to introduce the Rare Disease Cures Accelerator-Data and Analytics [...]
Whitepaper Highlights the Economic and Legislative Dangers of Mismatching Patient Data
A whitepaper released by LexisNexis details the dangers of improper data handling. Although managing patient data has been a longstanding [...]
ICER Releases Draft Evidence Report for AstraZeneca’s Asthma Drug
The Institute for Clinical and Economic Review (ICER) recently published its draft evidence report for asthma drug tezepelumab. The monoclonal [...]
Online Healthcare Technology Market Is Going to Boom with Optum, Cerner, Cognizant
Online Healthcare Technology Comprehensive Study by Type (Telehealth, Cloud Computing, Artificial Intelligence, Healthcare Analytics, Revenue Cycle Management (RCM), Picture Archiving [...]
Aetion and Quinten Health Announce Partnership to Facilitate RWE Studies and Improve Patient Outcomes
Aetion and artificial intelligence (AI) company Quinten Health have announced a partnership aimed at improving real world evidence (RWE) offerings [...]
“AARP and drug pricing”; LaGrange Daily News; 9-20-21
“Americans can’t afford to pay more than three times what people in other countries pay for the same medicine”-EVP Nancy [...]
Psychedelics Are a Billion-Dollar Business, and No One Can Agree Who Should Control It
In March, David Bronner, the "Cosmic Engagement Officer" of Dr. Bronner's Magic Soaps, wrote that it was “time to publicly [...]
Genomic Medicine Market to Grow with Modernizing Agro-Industry by 2026 | TechSci Research
Genomic Medicine Market to Grow with Modernizing Agro-Industry by 2026 | Read the source article at Business Social Network 2021-09-23 [...]
Medical Data Expert Shares Thoughts on RWE and Healthcare Research Challenges
In a recent interview, Savana Founder and Chief Medical Officer Ignacio H. Medrano shared his thoughts on emerging healthcare research [...]
Opinion: Seniors Need Lower Drug Prices Now, and H.R. 3 Won’t Stop Innovation
Here’s a simple fact: Many Californians are struggling to pay for their prescription drugs. This can mean going without their [...]
Understanding the Biden Administration’s Drug Pricing Plan
Insight September 23, 2021 Understanding the Biden Administration’s Drug Pricing Plan Executive Summary - The Department of Health and Human [...]
North American Health Economics & Outcomes Research (HEOR) Services Market, Forecast to 2027 – Leading Companies Focused on Product Launches and Expansions to Sustain Their Position – ResearchAndMarkets.com
DUBLIN, September 27, 2021 --( BUSINESS WIRE )--The "North America Health Economics and Outcomes Research Services Market Forecast to 2027 [...]
Health tech firm Elligo raises $135M from Cerner, other investors
Elligo Health Research, a company that uses electronic health records to facilitate patient access to clinical trials, has raised $135 [...]
Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment
Read the source article at Dove Medical Press 2021-09-27 16:05:06
“Pay for success” contracts – a model to develop new therapies from old drugs
Pay for Success Contracts — A New Model to Develop New Therapies from Old Drugs The problem — lack of [...]
Breakthrough Innovations in Healthcare Industry
Breakthrough Innovations in Healthcare Industry [IndustryARC Lifesciences and Healthcare] - Friday, September 24, 2021. Submitted by [IndustryARC] . Healthcare industry [...]
RWE Expert Discusses Ripple Effects of FDA Framework Throughout Pharma
In a recent interview, Roche’s Global Head of Real World Evidence (RWE) and Market Access Sreeram Ramagopalan shared his thoughts [...]
Evidence Partners Highlights the Time-Saving Power of AI in COVID-19 Data Extraction Case Study
In a recently described case study, a health agency was able to cut costs by using the DistillerSR artificial intelligence [...]